Heart Failure Biomarkers in COVID-19
Cardiac biomarkers may be abnormal in patients with COVID-19. Here a review of the interpretation of these markers in the context of the novel coronavirus.
Cardiac biomarkers may be abnormal in patients with COVID-19. Here a review of the interpretation of these markers in the context of the novel coronavirus.
Source Citation Maurer MS, Kale P, Fontana M, et al; APOLLO-B Trial Investigators. Patisiran treatment in patients with transthyretin cardiac amyloidosis. N Engl J Med.…
Evans’s Universal MindAlone. 1968
Oasis – ‘Wonderwall’ (Official Video)Taken from the album ‘(What’s The Story) Morning Glory?’Directed by: Nigel DickSUBSCRIBE ▶︎ https://Oasis.lnk.to/YTSubsc…
Heart failure (HF) is a global public health concern that affects millions of people worldwide. While there have been significant therapeutic advancements in HF over…
Heart failure (HF) is a global public health concern that affects millions of people worldwide. While there have been significant therapeutic advancements in HF over…
Abstract. Participants enrolled in cardiovascular disease (CVD) randomized controlled trials are not often representative of the population living with the dise
Abstract: There is widespread recognition, including among pregnant and lactating people, of the need for better evidence on which to…
Heart failure (HF) is a global public health concern that affects millions of people worldwide. While there have been significant therapeutic advancements in HF over…
Three-year outcomes of the Patient-Centered Care Transitions in Heart Failure (PACT-HF) stepped wedge cluster RCT in patients hospitalized for HF. Hospitals were randomized to a…
Nature Cardiovascular Research – Based on the 19th Global Cardiovascular Clinical Trialists meeting, this Perspective discusses potential sources of evidence that may be used to…